With regard to the procurement of COVID-19 rapid test kits: (a) how many kits have been procured since April 1, 2021, and what is the value of those kits, broken down by (i) month acquired, (ii) supplier from which they were acquired, (iii) provincial or territorial government, federal department or other entity to which they were provided; (b) what are the responses to (a), broken down by those procured under the authority of each of (i) section 1 of An Act respecting certain measures related to COVID-19 (S.C. 2022, c. 2), (ii) Vote 1c under the Department of Health and Vote 1c under the Public Health Agency of Canada of the Supplementary Estimates (C), 2021-22, enacted through the Appropriations Act No. 5, 2021-22 (S.C. 2022, c. 3), (iii) clause 46 of Bill C-8, An Act to implement certain provisions of the economic and fiscal update tabled in Parliament on December 14, 2021 and other measures, (iv) any other statutory or proposed retroactive statutory authority; (c) what are the details of the statutory or proposed retroactive statutory authorities referred to in (b)(iv); and (d) what is the balance outstanding on funds appropriated for the procurement of rapid tests, broken down by each authority referred to in (b)?
In the House of Commons on June 17th, 2022. See this statement in context.